SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001683168-23-007107
Filing Date
2023-10-12
Accepted
2023-10-12 18:00:09
Documents
1
Period of Report
2023-09-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4521
  Complete submission text file 0001683168-23-007107.txt   5910
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Issuer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ABEONA THERAPEUTICS INC. 1330 AVENUE OF THE AMERICAS - FLOOR 33 NEW YORK NY 10019
Business Address
Charles Faith L. (Reporting) CIK: 0001853985 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39126 | Film No.: 231323506